BIOMAT Database Logo BIOMAT Database Logo

Use of different tissue thromboplastins in the control of anticoagulant therapy. 1957

M VERSTRAETE, and P A CLARK, and I S WRIGHT

UI MeSH Term Description Entries
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013925 Thromboplastin Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation. Antigens, CD142,CD142 Antigens,Coagulation Factor III,Factor III,Tissue Factor,Tissue Thromboplastin,Blood Coagulation Factor III,Coagulin,Glomerular Procoagulant Activity,Prothrombinase,Tissue Factor Procoagulant,Urothromboplastin,Activity, Glomerular Procoagulant,Factor III, Coagulation,Procoagulant Activity, Glomerular,Procoagulant, Tissue Factor,Thromboplastin, Tissue

Related Publications

M VERSTRAETE, and P A CLARK, and I S WRIGHT
Use of different tissue thromboplastins in the control of anticoagulant-therapy.
November 1958, Thrombosis et diathesis haemorrhagica,
M VERSTRAETE, and P A CLARK, and I S WRIGHT
Differences in tissue thromboplastins and their influence on the control of anticoagulant therapy.
January 1958, Surgery,
M VERSTRAETE, and P A CLARK, and I S WRIGHT
Recombinant thromboplastins vs tissue-extract thromboplastins in patients on unstable oral anticoagulant therapy.
June 2011, Clinical chemistry,
M VERSTRAETE, and P A CLARK, and I S WRIGHT
Comparison of thromboplastins used for oral anticoagulant control.
October 1980, Pathology,
M VERSTRAETE, and P A CLARK, and I S WRIGHT
The calibration of rabbit tissue thromboplastins: experience of the Dutch Reference Laboratory for anticoagulant control.
October 1986, Journal of biological standardization,
M VERSTRAETE, and P A CLARK, and I S WRIGHT
Different sensitivities of various thromboplastins to two blood collection systems for monitoring oral anticoagulant therapy.
July 1999, Thrombosis and haemostasis,
M VERSTRAETE, and P A CLARK, and I S WRIGHT
[Anticoagulant therapy. Its use and control].
September 1960, L'union medicale du Canada,
M VERSTRAETE, and P A CLARK, and I S WRIGHT
Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
January 1990, Annales de biologie clinique,
M VERSTRAETE, and P A CLARK, and I S WRIGHT
The thermolability of tissue thromboplastins.
January 1966, Irish journal of medical science,
M VERSTRAETE, and P A CLARK, and I S WRIGHT
Homozygous FVII deficiencies with different reactivity towards tissue thromboplastins of different origin.
November 2012, Hematology (Amsterdam, Netherlands),
Copied contents to your clipboard!